论文部分内容阅读
目的:分析依那普利联合螺内酯治疗慢性心力衰竭的临床疗效。方法:选择慢性心力衰竭患者80例,按照随机数字表法将患者分成对照组和研究组,对照组进行常规治疗,研究组在对照组的基础上给予依那普利联合螺内酯进行治疗,对比两组血小板聚集功能和血液流变功能变化。结果:研究组的总有效率为92.5%,对照组的总有效率为75.0%,研究组明显优于对照组(P<0.05)。研究组的心率减慢、紫绀缓解、浮肿消退时间明显优于对照组(P<0.05)。结论:应用依那普利联合螺内酯治疗慢性心力衰竭,患者的血小板聚集、血流变学功能均可以获得明显改善,治疗效果明显,值得进行推广。
Objective: To analyze the clinical efficacy of enalapril combined with spironolactone in the treatment of chronic heart failure. Methods: Eighty patients with chronic heart failure were selected. According to the random number table, the patients were divided into control group and study group. The control group was treated routinely. The study group was treated with enalapril combined with spironolactone on the basis of control group. Platelet aggregation function and hemorrheological changes. Results: The total effective rate was 92.5% in the study group and 75.0% in the control group. The study group was significantly better than the control group (P <0.05). The study group’s heart rate slowed down, cyanosis relief, edema fade time was significantly better than the control group (P <0.05). Conclusion: Enalapril combined with spironolactone in the treatment of chronic heart failure, patients with platelet aggregation, hemorheology function can be significantly improved, the treatment effect is obvious, it is worth promoting.